Recurrent C. difficile can be debilitating, isolating, and sometimes life threatening. No one should have to live in fear of another infection.
That’s why we’re enrolling PRISM 3, a clinical study of investigational capsules designed to prevent the cycles of C. difficile.
What
study features
An oral pill designed to repair the microbiome – no bowel prep or colonoscopy
Dedicated, experienced medical care
Free transportation and coverage of all study-related costs
Who
eligibility criteria
18 years or older
Have had more than one episode of C. difficile infection
Have been prescribed antibiotics for the most recent C. difficile infection
Do not have inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS)
Where
how to enroll
If you or a loved one may be eligible, please use the map below to find and contact a participating doctor near you.
If there is no nearby site, or if you would like to learn more about the study, please contact us.
Ready to Join?
Enroll
—
Share the Study
